Kyverna Therapeutics, Inc. Common Stock Dividends
The next dividend date for Kyverna Therapeutics, Inc. Common Stock has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Kyverna Therapeutics, Inc. Common Stock (KYTX)
More About Kyverna Therapeutics, Inc. Common Stock
Kyverna Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and autoimmune diseases. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Owning Kyverna Therapeutics, Inc. Common Stock Stock on the Dividend Date
If you own Kyverna Therapeutics, Inc. Common Stock stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Kyverna Therapeutics, Inc. Common Stock stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Kyverna Therapeutics, Inc. Common Stock stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Kyverna Therapeutics, Inc. Common Stock stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Kyverna Therapeutics, Inc. Common Stock dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Kyverna Therapeutics, Inc. Common Stock Dividends
You can contact us any time if you would like to ask questions about Kyverna Therapeutics, Inc. Common Stock dividends or anything else related to the stock market.